| Entry |
|
|---|
| Name |
Sanilvudine (JAN);
Stavudine (USAN/INN);
Zerit (TN)
|
|---|
| Product |
|
|---|
| Generic |
STAVUDINE (Aurobindo Pharma Limited), STAVUDINE (Aurobindo Pharma Limited), STAVUDINE (Boca Pharmacal), STAVUDINE (Camber Pharmaceuticals), STAVUDINE (Cipla Limited), STAVUDINE (Edenbridge Pharmaceuticals), STAVUDINE (Greenstone LLC), STAVUDINE (KAISER FOUNDATION HOSPITALS), STAVUDINE (Mylan Pharmaceuticals), STAVUDINE (REMEDYREPACK), STAVUDINE (State of Florida DOH Central Pharmacy), STAVUDINE (State of Florida DOH Central Pharmacy) |
|---|
| Formula |
C10H12N2O4
|
|---|
| Exact mass |
224.0797
|
|---|
| Mol weight |
224.2133
|
|---|
| Structure |
     |
|---|
| Activity |
|
|---|
| Remark |
Same as: Therapeutic category: ATC code: |
|---|
| Comment |
Nucleoside reverse transcriptase inhibitor (NRTI)
|
|---|
| Target |
RNA-directed DNA polymerase inhibitor |
|---|
| Interaction |
|
|---|
| Structure map |
| Antiviral agents | | Anti-HIV agents |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D00445 Sanilvudine (JAN); Stavudine (USAN/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF04 Stavudine
D00445 Sanilvudine (JAN); Stavudine (USAN/INN)
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Stavudine
D00445 Sanilvudine (JAN); Stavudine (USAN/INN)
Antiinfectives [BR:br08307]
Antivirals
Anti-HIV agent
Reverse transcriptase inhibitor (RTI)
Nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs)
Sanilvudine [ATC:J05AF04]
D00445 Sanilvudine (JAN); Stavudine (USAN/INN)
 |
|---|
| Other DBs |
CAS: 3056-17-5 PubChem: DrugBank: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 16
1 C1y C 23.3375 -17.1684
2 N4y N 24.7304 -16.2773
3 O2x O 22.2047 -16.3383
4 C2x C 22.8796 -18.5037
5 C8y C 25.9417 -15.5769
6 C8x C 23.5292 -15.5678
7 C1y C 21.0616 -17.1462
8 C2x C 21.4815 -18.4900
9 N4x N 25.9604 -14.1782
10 O5x O 27.1422 -16.2880
11 C8y C 23.5311 -14.1636
12 C1b C 19.7320 -16.7119
13 C8y C 24.7525 -13.4704
14 C1a C 22.3517 -13.3997
15 O1a O 18.6814 -17.6318
16 O5x O 24.7621 -12.0810
BOND 17
1 1 2 1 #Up
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 4 8 2
8 5 9 1
9 5 10 2
10 6 11 2
11 7 12 1 #Up
12 9 13 1
13 11 14 1
14 12 15 1
15 13 16 2
16 7 8 1
17 11 13 1
|
|---|
